New injection aims to save Insulin-Making cells in type 1 diabetes
Disease control
Recruiting now
This study tests a new drug called OPT101 in adults diagnosed with type 1 diabetes within the last 20 years. Participants receive injections three times a week for up to one year. The goal is to see if OPT101 can safely help the body keep making its own insulin, reducing the need…
Phase: PHASE2 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC